📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Lypro Bio

1.1 - Company Overview

Lypro Bio Logo

Lypro Bio

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of NanoDisk drug delivery technology to increase solubility and bioavailability of hydrophobic drugs, with applications in cancer (curcumin and all-trans retinoic acid for glioblastoma multiforme and mantle cell lymphoma), infectious diseases (amphotericin B for Leishmania major and Aspergillosis), and neurodegenerative disease research; also offers Ambigent, an antifungal reagent for high-value cell cultures.

Products and services

  • Cancer Therapies: Curcumin-loaded NanoDisk systems deliver curcumin and all-trans retinoic acid to treat cancers, including glioblastoma multiforme and mantle cell lymphoma, improving bioavailability of these hydrophobic therapeutics
  • Infectious Diseases: Amphotericin B-based NanoDisk components deliver amphotericin B to address infections such as Leishmania major and Aspergillosis, enhancing solubility for antifungal efficacy in hydrophobic drug contexts
  • NanoDisk Technology: Nanometer-scale drug delivery platform constructs bioparticles that increase solubility and bioavailability of hydrophobic drugs

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Lypro Bio

Nurse Assist Logo

Nurse Assist

HQ: United States Website
  • Description: Provider of medical devices and USP sterile solutions, including prefilled saline syringes for IV flushing, sterile water and normal saline for irrigation and respiratory care, and sterile saline wound flush for moistening, debriding, and cleaning wounds, helping reduce contamination, medication errors, and needlestick injuries.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nurse Assist company profile →
Virpax Pharmaceuticals Logo

Virpax Pharmaceuticals

HQ: United States Website
  • Description: Provider of intranasal and topical therapeutics for pain, epilepsy, and viral inhibition, including: Probudur, a single-injection liposomal bupivacaine for extended post-operative pain; Envelta, intranasal enkephalin for acute/chronic and cancer pain; NobrXiol, intranasal CBD for rare pediatric epilepsy; AnQlar, intranasal spray to inhibit influenza/SARS-CoV-2; and Epoladerm, topical diclofenac spray film for osteoarthritis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Virpax Pharmaceuticals company profile →
Innocoll Logo

Innocoll

HQ: United States Website
  • Description: Provider of targeted drug delivery solutions focused on biodegradable surgical implants and topically applied healthcare products, including XARACOLL, a resorbable collagen implant with bupivacaine for pain relief up to 24 hours after open inguinal hernia repair; POSIMIR, a single‑site bupivacaine injection providing relief up to 72 hours after arthroscopic subacromial decompression; the COLLARx collagen matrix platform; and CDMO services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Innocoll company profile →
Stratagent Life Sciences Logo

Stratagent Life Sciences

HQ: United States Website
  • Description: Provider of specialty drug therapies that are painless and non-invasive for various diseases, developing alternatives to injected treatments based on proprietary microjet technology to deliver large and small therapeutic molecules without a device penetrating into or through the skin.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Stratagent Life Sciences company profile →
Acorda Therapeutics Logo

Acorda Therapeutics

HQ: United States Website
  • Description: Provider of commercial-stage biopharmaceutical therapies, identifying, developing and commercializing therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other nervous system disorders. Products include INBRIJA (levodopa inhalation powder for Parkinson’s symptoms), AMPYRA (dalfampridine to improve walking in adults with MS), and the ARCUS drug delivery platform.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Acorda Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Lypro Bio

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Lypro Bio

2.2 - Growth funds investing in similar companies to Lypro Bio

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Lypro Bio

4.2 - Public trading comparable groups for Lypro Bio

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Lypro Bio

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Lypro Bio

What does Lypro Bio do?

Lypro Bio is a provider of NanoDisk drug delivery technology to increase solubility and bioavailability of hydrophobic drugs, with applications in cancer (curcumin and all-trans retinoic acid for glioblastoma multiforme and mantle cell lymphoma), infectious diseases (amphotericin B for Leishmania major and Aspergillosis), and neurodegenerative disease research; also offers Ambigent, an antifungal reagent for high-value cell cultures.

Who are Lypro Bio's competitors?

Lypro Bio's competitors and similar companies include Nurse Assist, Virpax Pharmaceuticals, Innocoll, Stratagent Life Sciences, and Acorda Therapeutics.

Where is Lypro Bio headquartered?

Lypro Bio is headquartered in United States.

How many employees does Lypro Bio have?

Lypro Bio has 1,000 employees 🔒.

When was Lypro Bio founded?

Lypro Bio was founded in 2010 🔒.

What sector and industry vertical is Lypro Bio in?

Lypro Bio is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Lypro Bio

Who are the top strategic acquirers in Lypro Bio's sector and industry

Top strategic M&A buyers and acquirers in Lypro Bio's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Lypro Bio?

Top strategic M&A buyers groups and sectors for Lypro Bio include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Lypro Bio's sector and industry vertical

Which are the top PE firms investing in Lypro Bio's sector and industry vertical?

Top PE firms investing in Lypro Bio's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Lypro Bio's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Lypro Bio's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Lypro Bio's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Lypro Bio include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Lypro Bio's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Lypro Bio?

The key public trading comparables and valuation benchmarks for Lypro Bio include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Lypro Bio for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Lypro Bio with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Lypro Bio's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Lypro Bio with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Lypro Bio's' sector and industry vertical?

Access recent funding rounds and capital raises in Lypro Bio's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Lypro Bio

Launch login modal Launch register modal